Alertgy NICGM wristband targets painless non-invasive blood sugar monitoring for Type 2 diabetics by 2023

There are quite a few companies working on a pain-free method for diabetes sufferers to measure their blood sugar levels throughout the day; however, many of these promised devices seem to be a few years away from market. An "early 2023" launch, pending FDA approval, is on the cards for the Alertgy NICGM wristband, as an earlier assurance of making "the device available for purchase no later than 2022" seems to have gone awry, which is understandable considering the events of the last two years. While the COVID-19 pandemic may have placed some obstacles in the way for the 2022 launch to happen, there are some exciting developments for those interested in the Alertgy NICGM wristband.

Firstly, the US-based company has been invited to the 3rd annual European Healthtech CEO Forum that is being held virtually on February 28. This could be a big step for the biotech startup, especially if it has something specific to reveal in regard to diabetes and its management. The second interesting note for those hoping for a pain-free method to check their blood sugar levels on a regular basis is that Alertgy is looking for two groups of volunteers: One set to work as a focus group to give the engineers a better idea of what to put together and another set to test the Alertgy NICGM wristband when required.

The non-invasive continuous glucose monitor wristband is paired with a custom app on the wearer’s smartphone, allowing for continual sharing of data. The wristband uses patented technology involving dielectric spectroscopy and radio waves to detect a specific “chemical signature” in the blood, thus removing the requirement for lancets and painful finger-sticking. The wristband can provide alerts for when sugar levels are either too high or too low and is targeted for users with Type 2 diabetes.

Alertgy has been working on the NICGM wristband for some years now and took a massive step toward completion when awarded the US patent for “apparatus for in vivo dielectric spectroscopy” in early 2021. A prototype is being worked on and the device itself should see the light of day in early 2023 if Alertgy wants to meet its goals. The blood sugar monitor will be designed to be waterproof and hypoallergenic while the cost of the wearable will be “as inexpensive as possible”. Interested parties can sign up or learn more about the Alertgy NICGM wristband via the company’s official website.

Buy the Care Touch Diabetes Testing Kit on Amazon